WAUI
BIO icon

WELLINGTON-ALTUS USA INC.’s Bio-Rad Laboratories Class A BIO Stock Holding History

WELLINGTON-ALTUS USA INC.’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.2K Hold
101
– – 0.02% 431
2026
Q1 		$29.7K Buy
101
+23
+29% +$6.62K 0.02% 444
2025
Q4 		$23.6K Buy
+78
New +$24.3K 0.02% 452

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

WELLINGTON-ALTUS USA INC.'s BIO Position: Q2 2026 in Review

WELLINGTON-ALTUS USA INC. held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 101 shares worth $28.2K. The position accounts for 0.02% of the portfolio, ranked #431.

WELLINGTON-ALTUS USA INC. first reported a position in BIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $29.7K in Q1 2026. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • WELLINGTON-ALTUS USA INC. held 101 shares of Bio-Rad Laboratories Class A worth $28.2K as of Q2 2026.
  • WELLINGTON-ALTUS USA INC. left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up 0.02% of WELLINGTON-ALTUS USA INC.'s portfolio in Q2 2026, its #431 holding.
  • WELLINGTON-ALTUS USA INC. first reported a position in Bio-Rad Laboratories Class A in Q4 2025 and has held it in 3 quarters since.
  • WELLINGTON-ALTUS USA INC.'s Bio-Rad Laboratories Class A position peaked at $29.7K in Q1 2026.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on WELLINGTON-ALTUS USA INC.'s 13F filing for Q2 2026, filed 17 Sep 2026.